In the latest trading session, 0.43 million 908 Devices Inc (NASDAQ:MASS) shares changed hands as the company’s beta touched 0.97. With the company’s most recent per share price at $1.84 changed hands at -$0.06 or -3.42% at last look, the market valuation stands at $63.90M. MASS’s current price is a discount, trading about -579.89% off its 52-week high of $12.51. The share price had its 52-week low at $1.82, which suggests the last value was 1.09% up since then. When we look at 908 Devices Inc’s average trading volume, we note the 10-day average is 0.26 million shares, with the 3-month average coming to 239.98K.
Analysts gave the 908 Devices Inc (MASS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.40. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended MASS as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. 908 Devices Inc’s EPS for the current quarter is expected to be -0.37.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
908 Devices Inc (NASDAQ:MASS) trade information
Instantly MASS was in red as seen in intraday trades today. With action -9.61%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -83.65%, with the 5-day performance at -9.61% in the red. However, in the 30-day time frame, 908 Devices Inc (NASDAQ:MASS) is -28.32% down. Looking at the short shares, we see there were 1.38 million shares sold at short interest cover period of 3.57 days.
908 Devices Inc (MASS) estimates and forecasts
Data shows that the 908 Devices Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -63.30% over the past 6 months, a -76.11% in annual growth rate that is considerably lower than the industry average of 15.50%. Year-over-year growth is forecast to reach 13.44% up from the last financial year.
Consensus estimates given by 5 financial analysts project the company’s revenue in the current quarter to hit an average of 16.18M. 3 analysts are of the opinion that 908 Devices Inc’s revenue for the current quarter will be 13.43M. The company’s revenue for the corresponding quarters a year ago was 14.35M and 9.99M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 12.73%. The estimates for the next quarter sales put growth at 34.45%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -31.19%. The 2024 estimates are for 908 Devices Inc earnings to decrease by -48.32%.
MASS Dividends
908 Devices Inc is expected to release its next quarterly earnings report in January.
908 Devices Inc (NASDAQ:MASS)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 8.21% of 908 Devices Inc shares while 69.75% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 75.99%. There are 69.75% institutions holding the 908 Devices Inc stock share, with ARK INVESTMENT MANAGEMENT LLC the top institutional holder. As of 2024-06-30, the company held 12.0377% of the shares, roughly 3.94 million MASS shares worth $20.28 million.
AMERIPRISE FINANCIAL INC holds the second largest percentage of outstanding shares, with 5.7552% or 1.88 million shares worth $9.7 million as of 2024-06-30.
Among Mutual Funds, the top two as of Oct 31, 2024 were ARK ETF Tr-ARK Genomic Revolution ETF and Columbia Fds Ser Tr I-Columbia Small Cap Growth Fd I. With 3.13 shares estimated at $5.75 million under it, the former controlled 8.97% of total outstanding shares. On the other hand, Columbia Fds Ser Tr I-Columbia Small Cap Growth Fd I held about 4.33% of the shares, roughly 1.51 shares worth around $2.78 million.
